Targeting brain immune cells for early Alzheimer's disease
Microglia targeted interventions in prodromal Alzheimer's disease stage
This research explores ways to protect the brain from Alzheimer's disease by focusing on special immune cells called microglia, especially in people who are just starting to show signs of the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11111423 on NIH RePORTER |
What this research studies
Our brains have immune cells called microglia that usually help clear away harmful substances and protect against Alzheimer's disease. However, certain genetic factors, like the APOE4 gene, can cause these microglia to become overactive and actually contribute to the disease by causing too much inflammation. This project aims to find new treatments that can calm these overactive microglia and prevent damage in important memory areas of the brain, such as the entorhinal cortex and hippocampus. By targeting these cells early, we hope to stop Alzheimer's disease from progressing before significant memory loss occurs.
Who could benefit from this research
Good fit: This research is most relevant to individuals in the prodromal stage of Alzheimer's disease, particularly those with genetic risk factors like the APOE4 allele.
Not a fit: Patients with advanced Alzheimer's disease or those without the specific genetic risk factors being studied may not directly benefit from this particular research focus.
Why it matters
Potential benefit: If successful, this research could lead to new medications or cell therapies that protect vulnerable brain regions and slow or prevent the progression of Alzheimer's disease in its early stages.
How similar studies have performed: Previous work has shown that certain drugs can affect microglia, suggesting that targeting these cells is a promising approach for brain conditions.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Tcw, Julia — Boston University Medical Campus
- Study coordinator: Tcw, Julia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.